Lonza has released information on infection control for human coronavirus, a group of viruses that principally infect the gastrointestinal and upper respiratory tract of mammals and birds. Human infections with coronaviruses such as Severe Acute Respiratory Syndrome (SARS-CoV) and MERS-CoV have raised global health concerns. These strains may cause severe disease and have pandemic potential.
In addition to basic and general hygiene procedures to reduce infection risk, Lonza’s Hygiene and Preservation business offers formulations for use as hard surface disinfectant cleaners and for hand hygiene. Multiple Lonzagard formulations have been tested against other coronavirus strains and have demonstrated full activity. These include Lonzagard HWS-256 germicidal detergent solution and Lonzagard Disinfectant Wipes within the U.S. Non-U.S. Lonzagard formulations include Lonzagard DR-25aN disinfectant cleaner which meets the ‘virucidal’ definition.
Lonza Issues Guidance on Infection Control
Published August 30, 2013
blog comments powered by Disqus